The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 36, No. 11, pp. 1767-1775. DOI 10.1345/aph.1A160
© 2002 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malnick, S.
Right arrow Articles by Zimhony, O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malnick, S.
Right arrow Articles by Zimhony, O

Research Articles

Treatment of Clostridium difficile-associated diarrhea

SD Malnick and O Zimhony

OBJECTIVE: To review the literature related to the treatment and infection control of Clostridium difficile-associated diarrhea (CDAD). DATA SOURCES: A MEDLINE search (1966-August 2001) of the English literature was conducted. DATA SYNTHESIS: C. difficile is a leading cause of antibiotic-related diarrhea. The clinical spectrum extends from simple diarrhea to fulminant colitis. Cessation of antibiotic therapy alone is sufficient for mild cases; however, the majority of cases require oral metronidazole as the drug of choice. Vancomycin orally is reserved for patients who have failed to respond to metronidazole, are pregnant, or are severely ill. There is an important role for infection control interventions. CONCLUSIONS: CDAD is a common infection. Appropriate antibiotic treatment and infection control policies can prevent the spread and reduce the morbidity associated with this disease.


This article has been cited by other articles:


Home page
 Journal of the American Dental AssociationHome page
D. B. Blossom, F. M.T. Lewis, and L. C. McDonald
The Changing Spectrum of Clostridium Difficile Associated Disease: Implications for Dentistry
J Am Dent Assoc, January 1, 2008; 139(1): 42 - 47.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
T. Z Jodlowski, R. Oehler, L. W Kam, and I. Melnychuk
Emerging Therapies in the Treatment of Clostridium difficile-Associated Disease
Ann. Pharmacother., December 1, 2006; 40(12): 2164 - 2169.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R. M Cadle, M. D Mansouri, and R. O Darouiche
Vancomycin-Induced Elevation of Liver Enzyme Levels
Ann. Pharmacother., June 1, 2006; 40(6): 1186 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
S. M. Poutanen and A. E. Simor
Treating C. difficile
Can. Med. Assoc. J., February 15, 2005; 172(4): 448 - 448.
[Full Text] [PDF]

Home page
 CMAJHome page
S. M. Poutanen and A. E. Simor
Clostridium difficile-associated diarrhea in adults
Can. Med. Assoc. J., July 6, 2004; 171(1): 51 - 58.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2002 by Harvey Whitney Books Company.